Teladoc Health, Inc. (TDOC): Price and Financial Metrics


Teladoc Health, Inc. (TDOC)

Today's Latest Price: $222.23 USD

1.46 (-0.65%)

Updated Oct 20 7:00pm

Add TDOC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 70 in Medical - Services

See all "A" rated Strong Buy stocks

TDOC Stock Summary

  • With a one year PEG ratio of 2,137.05, Teladoc Health Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 98.08% of US stocks.
  • The price/operating cash flow metric for Teladoc Health Inc is higher than 98.75% of stocks in our set with a positive cash flow.
  • TDOC's price/sales ratio is 25.37; that's higher than the P/S ratio of 93.46% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Teladoc Health Inc, a group of peers worth examining would be HZNP, BL, EXAS, AKAM, and AYX.
  • Visit TDOC's SEC page to see the company's official filings. To visit the company's web site, go to www.teladochealth.com.

TDOC Stock Price Chart Interactive Chart >

Price chart for TDOC

TDOC Price/Volume Stats

Current price $222.23 52-week high $253.00
Prev. close $223.69 52-week low $66.23
Day low $221.29 Volume 1,274,862
Day high $226.26 Avg. volume 3,131,709
50-day MA $210.88 Dividend yield N/A
200-day MA $173.36 Market Cap 18.44B

Teladoc Health, Inc. (TDOC) Company Bio


Teladoc Health provides telehealth services via mobile devices, the Internet, video, and phone to clients and their customers in the United States. The company was founded in 2002 and is based in Dallas, Texas.

TDOC Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$222.23$115877.69 51703%

Below please find a table outlining a discounted cash flow forecast for TDOC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Teladoc Health Inc ranked in the 99th percentile in terms of potential gain offered. Our DCF model suggests the stock is undervalued by 51956.83%; returns of such proportions should be viewed with some skepticism, though. As for the metrics that stood out in our discounted cash flow analysis of Teladoc Health Inc, consider:

  • In the past 1 years, Teladoc Health Inc has a compound free cash flow growth rate of 6.42%; that's higher than 97.18% of free cash flow generating stocks in the Technology sector.
  • The business' balance sheet suggests that 5% of the company's capital is sourced from debt; this is greater than merely 15.51% of the free cash flow producing stocks we're observing.
  • Teladoc Health Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -1.89. This coverage rate is greater than that of merely 17.08% of stocks we're observing for the purpose of forecasting via discounted cash flows.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%50687%
1%51195%
2%51703%
3%52211%
4%52719%
5%53226%

ASX, ZNGA, ALYA, BL, and DCMYY can be thought of as valuation peers to TDOC, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.


TDOC Latest News Stream


Event/Time News Detail
Loading, please wait...

TDOC Latest Social Stream


Loading social stream, please wait...

View Full TDOC Social Stream

Latest TDOC News From Around the Web

Below are the latest news stories about Teladoc Health Inc that investors may wish to consider to help them evaluate TDOC as an investment opportunity.

Online Doctor Consultation Market is Gaining Momentum with key players LiveHealth Online, Babylon Health, TelaDoc

A New Syndicate COVID-19 Outbreak-Global Online Doctor Consultation Market Study is added in HTF MI database compiled covering key business segments and wider geographical scope to get deep dive analysed market data. The study brings a perfect bridging between qualitative

OpenPR | October 1, 2020

Cramer Weighs In On Disney, Teladoc And More

On CNBC's "Mad Money Lightning Round," Jim Cramer said Switchback Energy Acquisition Ord Shs Class A (NYSE: SBE ) is another blank-check company. Until we find out more about it, we don't know if we have another Nikola Corporation (NASDAQ: NKLA ), added Cramer. Cramer's … Full story available on Benzinga.com

Benzinga | September 30, 2020

Stay-At-Home Stock Play Teladoc Set For Q3 Beat, DA Davidson Says In Bullish Initiation

The telehealth company Teladoc Health Inc (NYSE: TDOC ) has posted strong gains during the coronavirus pandemic. The Teladoc Analyst: D.A. Davidson analyst Hannah Baade initiated coverage of Teladoc with a Buy rating and $250 price target. The Teladoc Thesis: Teladoc, being a pure play software company directly benefiting from COVID-19, is growing at a more than 60% pace organically, Baade said in an initiation note. Telehealth utilization soared to 16% during COVID-19, and it could go up to 25% in the long term, equating to a $250-billion market going forward, the analyst said. Acquisitions have further expanded markets and provided leverage to popular direct-to-consumer … Full story available on Benzinga.com

Benzinga | September 22, 2020

Top Analyst Upgrades and Downgrades: Alibaba, Amazon, Apple, Carvana, Illumina, NextEra, Nikola, Shake Shack, Teladoc, WPX Energy and More

No summary available.

24/7 Wall street | September 22, 2020

Telehealth company Amwell is going public after raising $742 million in its IPO. Here are the investors and execs who stand to make the most.

Summary List Placement American Well raised $742 million ahead of its public market debut, pricing at $18 a share late Wednesday. The stock is set to start trading Thursday morning. As the company goes public, executives including Ido and Roy Schoenberg, the company's founders and CEOs, and investors including Teva Pharmaceuticals stand to make hundreds of millions. The IPO comes on the heels of a huge year for digital health as the coronavirus pandemic fueled Amwell and similar companies to new heights. It's only the second telehealth company to go public, following rival Teladoc's public debut in 2015. SVB Leerink's Stephanie Davis, a healthcare analyst, said the IPO is leading to "the match we've all been waiting for" in an email to investors. But she also said the Teladoc-Amwell riv...

Business Insider | September 17, 2020

Read More 'TDOC' Stories Here

TDOC Price Returns

1-mo 9.66%
3-mo 1.07%
6-mo 14.83%
1-year 226.09%
3-year 548.85%
5-year 1,121.04%
YTD 165.44%
2019 68.89%
2018 42.24%
2017 111.21%
2016 -8.13%
2015 N/A

Continue Researching TDOC

Here are a few links from around the web to help you further your research on Teladoc Health Inc's stock as an investment opportunity:

Teladoc Health Inc (TDOC) Stock Price | Nasdaq
Teladoc Health Inc (TDOC) Stock Quote, History and News - Yahoo Finance
Teladoc Health Inc (TDOC) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7347 seconds.